Biotechnology Stocks I: Compare Returns of S&P 500 to NewAmsterdam Pharma Company N.V. (NAMS)
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| Compare Returns for S&P 500 and NAMS | ||
|---|---|---|
| S&P 500 | NAMS | |
| Start Date | Jan-01-2023 | Dec-30-2022 |
| Start Price | $2,800.75 | $10.90 |
| End Date | Apr-11-2025 | Apr-22-2025 |
| End Price | $5,363.36 | $16.79 |
| Number Monthly Prices | 29 | 29 |
| Min Date | Mar-01-2023 | Oct-31-2023 |
| Min Price | $4,146.44 | $9.00 |
| Max Date | Dec-01-2024 | Dec-31-2024 |
| Max Price | $6,010.09 | $25.70 |
| Total Return | 28.46% | 54.04% |
| Annualized Return | 10.92% | 19.57% |
| Current Value of $1,000 Purchase | $1,285 | $1,540 |
| Number Returns | 406 | 406 |
| Average Return | 15.57% | 36.39% |
| Minimum Return | -10.76% | -36.75% |
| Maximum Return | 44.95% | 185.56% |
| Number Profitable Returns | 372 | 280 |
| Percent Profitable Returns | 91.63% | 68.97% |
| Number Unprofitable Returns | 34 | 126 |
| Percent Unprofitable Returns | 8.37% | 31.03% |
| Profitable to Unprofitable Returns Ratio | 10.94 | 2.22 |
NAMS Performance Table and Chart
NAMS Dollar-cost Average
NAMS Trendline Chart
NAMS Moving Average Chart
NAMS Stock Return Map - See Patterns of Gains and Losses
NAMS Stock Returns/Purchase Dates